Previous Close | 20.60 |
Open | 20.60 |
Bid | 15.10 |
Ask | 23.00 |
Strike | 110.00 |
Expire Date | 2026-01-16 |
Day's Range | 20.60 - 20.60 |
Contract Range | N/A |
Volume | |
Open Interest | 526 |
Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the first quarter of fiscal year 2024, which include the consolidated financial results for GRAIL.
AbCellera Biologics (ABCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
In Cambridge, United Kingdom, Illumina champions STEM education opportunities with local students NORTHAMPTON, MA / ACCESSWIRE / April 29, 2024 / Illumina Originally published on Illumina News Center On April 25, Illumina opened its doors in Granta ...